KOSDAQ - Delayed Quote KRW

Hironic Co., Ltd. (149980.KQ)

Compare
8,610.00 -500.00 (-5.49%)
At close: July 26 at 3:30 PM GMT+9
Loading Chart for 149980.KQ
DELL
  • Previous Close 9,110.00
  • Open 9,060.00
  • Bid 8,610.00 x --
  • Ask 8,620.00 x --
  • Day's Range 8,410.00 - 9,350.00
  • 52 Week Range 6,266.67 - 11,616.67
  • Volume 486,263
  • Avg. Volume 719,978
  • Market Cap (intraday) 144.818B
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 29, 2020
  • 1y Target Est 16,000.00

Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy. The company was founded in 2007 and is headquartered in Yongin-Si, South Korea.

www.hironic.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 149980.KQ

View More

Performance Overview: 149980.KQ

Trailing total returns as of 7/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

149980.KQ
10.74%
KOSPI Composite Index
2.89%

1-Year Return

149980.KQ
20.00%
KOSPI Composite Index
5.38%

3-Year Return

149980.KQ
86.90%
KOSPI Composite Index
15.29%

5-Year Return

149980.KQ
114.67%
KOSPI Composite Index
32.21%

Compare To: 149980.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 149980.KQ

View More

Valuation Measures

Annual
As of 7/26/2024
  • Market Cap

    144.82B

  • Enterprise Value

    124.99B

  • Trailing P/E

    19.15

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.70

  • Price/Book (mrq)

    1.98

  • Enterprise Value/Revenue

    3.47

  • Enterprise Value/EBITDA

    9.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    24.92%

  • Return on Assets (ttm)

    4.82%

  • Return on Equity (ttm)

    13.59%

  • Revenue (ttm)

    35.97B

  • Net Income Avi to Common (ttm)

    8.87B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.84B

  • Total Debt/Equity (mrq)

    0.02%

  • Levered Free Cash Flow (ttm)

    -4.34B

Research Analysis: 149980.KQ

View More

Company Insights: 149980.KQ

Research Reports: 149980.KQ

View More

People Also Watch